Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 -190.80M
March 31, 2026 -159.00M
December 31, 2025 -322.00M
September 30, 2025 -163.30M
June 30, 2025 -1.384B
March 31, 2025 -106.00M
December 31, 2024 -291.20M
September 30, 2024 -154.90M
June 30, 2024 -247.00M
March 31, 2024 -195.00M
December 31, 2023 -220.80M
September 30, 2023 -165.60M
June 30, 2023 -243.10M
March 31, 2023 -149.40M
December 31, 2022 -112.50M
September 30, 2022 -85.20M
June 30, 2022 -243.20M
March 31, 2022 -88.30M
December 31, 2021 -146.20M
September 30, 2021 -125.20M
June 30, 2021 -109.90M
March 31, 2021 -122.30M
December 31, 2020 -315.90M
September 30, 2020 -91.40M
June 30, 2020 -85.30M
Date Value
March 31, 2020 -121.20M
December 31, 2019 -138.00M
September 30, 2019 -163.60M
June 30, 2019 -322.20M
March 31, 2019 -105.50M
December 31, 2018 -82.40M
September 30, 2018 -138.90M
June 30, 2018 -93.60M
March 31, 2018 -101.70M
December 31, 2017 -128.20M
September 30, 2017 -120.50M
June 30, 2017 -129.00M
March 31, 2017 -133.10M
December 31, 2016 -146.80M
September 30, 2016 -1.374B
June 30, 2016 -266.20M
March 31, 2016 95.80M
December 31, 2015 121.50M
September 30, 2015 41.30M
June 30, 2015 -7.789B
March 31, 2015 67.90M
December 31, 2014 28.70M
September 30, 2014 -229.40M
June 30, 2014 -170.30M
March 31, 2014 -98.40M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. -26.60M
Stryker Corp. -639.00M
Globus Medical, Inc. -129.05M
Boston Scientific Corp. -1.956B
Inspire Medical Systems, Inc. 3.548M